Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

OHRP

Ohr Pharmaceuticals, Inc. (OHRP)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OHRP
DataOraFonteTitoloSimboloCompagnia
03/10/201923:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
24/09/201912:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
23/09/201923:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
13/09/201923:19Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
27/08/201916:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
16/08/201923:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
14/08/201923:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
23/07/201915:59Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
17/07/201923:27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
11/07/201923:28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
03/07/201916:00GlobeNewswire Inc.Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019NASDAQ:OHRPOhr Pharmaceuticals, Inc.
07/06/201916:28Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
03/06/201923:22Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
15/05/201922:01GlobeNewswire Inc.Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019NASDAQ:OHRPOhr Pharmaceuticals, Inc.
08/03/201923:21Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
21/02/201916:45GlobeNewswire Inc.Ohr Pharmaceutical Regains Compliance with NASDAQ Listing RequirementsNASDAQ:OHRPOhr Pharmaceuticals, Inc.
09/01/201921:45PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Ohr Pharmaceutical, Inc.NASDAQ:OHRPOhr Pharmaceuticals, Inc.
04/01/201913:40PR Newswire (US)LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr PharmaceuticalNASDAQ:OHRPOhr Pharmaceuticals, Inc.
03/01/201916:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
31/12/201822:38Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
18/12/201823:05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
07/12/201822:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
14/08/201822:05GlobeNewswire Inc.Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial ResultsNASDAQ:OHRPOhr Pharmaceuticals, Inc.
15/05/201822:05GlobeNewswire Inc.Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial ResultsNASDAQ:OHRPOhr Pharmaceuticals, Inc.
13/03/201812:32GlobeNewswire Inc.Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical OfficerNASDAQ:OHRPOhr Pharmaceuticals, Inc.
15/02/201823:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
14/02/201822:05GlobeNewswire Inc.Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial ResultsNASDAQ:OHRPOhr Pharmaceuticals, Inc.
06/12/201721:43Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
19/10/201700:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
16/05/201723:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OHRPOhr Pharmaceuticals, Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OHRP
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network